Background glaucoma Shape Background glaucoma Shape Background glaucoma Shape
Grants > Are Mice Good Models of IOP Regulation in Human Eyes? Updated On: Ene. 23, 2025
National Glaucoma Research Grant

Are Mice Good Models of IOP Regulation in Human Eyes?

Darryl Overby, PhD

Principal Investigator

Darryl Overby, PhD

Imperial College London

London, United Kingdom

About the Research Project

Program

National Glaucoma Research

Award Type

Standard

Award Amount

$100,000

Active Dates

July 01, 2011 - June 30, 2013

Grant ID

G2011020

Acknowledgement

Recipient of the Thomas R. Lee Award for National Glaucoma Research.

Goals

The success of glaucoma therapies depends on how well they lower pressure in the eye, and these therapies are often developed with the help of animal models such as mice. However, it is not entirely clear whether the mechanisms controlling pressure in mouse eyes are representative of the pressure controlling mechanisms in human eyes. This project investigates whether mice are good animal models in which to develop better therapies to more successfully lower pressure in human eyes.

Grantee institution at the time of this grant: Tulane University

Summary

The success of glaucoma therapies depends on how well they lower pressure in the eye, and successful therapies are often developed with the help of animal models such as mice. However, a drug found to lower pressure in mice is useless in humans if the machinery controlling eye pressure is different between the two species. Recent studies suggest that pressure regulation in some strains of mice relies more heavily on a secondary or “uveoscleral” pathway for fluid drainage from the eye, while human pressure regulation depends more on the primary or “trabecular” drainage pathway. Not all strains of mice, however, appear to exhibit the same preference for drainage routes, suggesting that some strains may better represent the trabecular pressure regulation as occurs in humans. In this project, Dr. Darryl Overby and colleagues will examine genetically distinct strains of mice chosen based upon their apparent differences in drainage behaviour, with the goal to identify which of these strains best mimics the machinery that controls pressure in human eyes. This is an important first step towards establishing a reliable mouse model that can be used to develop better therapies that more successfully lower pressure and preserve vision in glaucoma patients.

 

Progress Updates

Dr. Overby’s team’s progress over the past year has established that mouse eyes share similar pressure-regulating pharmacological and physiological mechanisms as previously reported in human eyes. These studies will help to establish whether mice are good animal models in which to screen and develop improved therapies to more successfully lower pressure in human eyes, ultimately to better preserve vision in glaucoma patients.